BRA
Bender Robert & Associates Portfolio holdings
AUM
$448M
This Quarter Return
+14.38%
1 Year Return
+20.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$352M
AUM Growth
+$352M
(+13%)
Cap. Flow
+$690K
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
71.31%
Holding
57
New
1
Increased
28
Reduced
10
Closed
10
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$3.23M |
| 2 |
Advanced Micro Devices
AMD
|
$983K |
| 3 |
Microsoft
MSFT
|
$491K |
| 4 |
Amazon
AMZN
|
$396K |
| 5 |
Five Below
FIVE
|
$246K |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$3.06M |
| 2 |
UroGen Pharma
URGN
|
$606K |
| 3 |
AT&T
T
|
$358K |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$351K |
| 5 |
Evolus
EOLS
|
$325K |
Sector Composition
| 1 | Technology | 33.5% |
| 2 | Consumer Discretionary | 28.93% |
| 3 | Healthcare | 22.13% |
| 4 | Communication Services | 12.42% |
| 5 | Industrials | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pulse Biosciences
PLSE
$1.03B
| – | – |
-8,825
| Closed | -$209K |
|
52
Summit Therapeutics
SMMT
$17.7B
| – | – |
-14,059
| Closed | -$83K |
|
|
53
AT&T
T
$208B
| – | – |
-11,828
| Closed | -$358K |
|
|
54
UroGen Pharma
URGN
$890M
| – | – |
-31,131
| Closed | -$606K |
|
|
CMRX
55
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-10,000
| Closed | -$96K |
|
|
JNCE
56
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-10,000
| Closed | -$103K |
|
|
CLVS
57
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-50,000
| Closed | -$351K |
|